BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 31090131)

  • 1. Dermatomyofibroma-A rare mesenchymal tumor with maintained horripilation.
    Wollina U; Schönlebe J
    Dermatol Ther; 2019 Jul; 32(4):e12967. PubMed ID: 31090131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque-like CD34-positive dermal fibroma ("medallion-like dermal dendrocyte hamartoma"): clinicopathologic, immunohistochemical, and molecular analysis of 5 cases emphasizing its distinction from superficial, plaque-like dermatofibrosarcoma protuberans.
    Kutzner H; Mentzel T; Palmedo G; Hantschke M; Rütten A; Paredes BE; Schärer L; Guillen CS; Requena L
    Am J Surg Pathol; 2010 Feb; 34(2):190-201. PubMed ID: 20061935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dermatofibrosarcoma protuberans with a novel COL6A3-PDGFD fusion gene and apparent predilection for breast.
    Dickson BC; Hornick JL; Fletcher CDM; Demicco EG; Howarth DJ; Swanson D; Zhang L; Sung YS; Antonescu CR
    Genes Chromosomes Cancer; 2018 Sep; 57(9):437-445. PubMed ID: 30014607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dermatofibrosarcoma protuberans: a tumor in the wide spectrum of the bland-looking spindle cell lesions of the breast.
    Vecchio GM; Broggi G; Mulè A; Piombino E; Magro G
    Pathologica; 2019 Sep; 111(3):87-91. PubMed ID: 31748754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophic dermatofibrosarcoma protuberans with the fusion gene COL1A1-PDGFB.
    Llombart B; Sanmartin O; Requena C; Monteagudo C; Botella-Estrada R; Nagore E; Serra C; Alfaro A; Pellín A; Llombart-Bosch A; Guillén C; López-Guerrero JA
    J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):371-4. PubMed ID: 18005119
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetics of dermatofibrosarcoma protuberans family of tumors: from ring chromosomes to tyrosine kinase inhibitor treatment.
    Sirvent N; Maire G; Pedeutour F
    Genes Chromosomes Cancer; 2003 May; 37(1):1-19. PubMed ID: 12661001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
    Wu JK; Malik MM; Egan CA
    Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pigmented dermatofibrosarcoma protuberans (Bednár tumor) occurring in a Japanese infant.
    Kaburagi Y; Hatta N; Kawara S; Takehara K
    Dermatology; 1998; 197(1):48-51. PubMed ID: 9693186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Congenital myxoid and pigmented dermatofibrosarcoma protuberans: a case report.
    El Hachem M; Diociaiuti A; Latella E; Zama M; Lambiase C; Giraldi L; Surrenti T; Callea F
    Pediatr Dermatol; 2013; 30(5):e74-7. PubMed ID: 23534369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dermatofibrosarcoma protuberans: clinicopathological aspects of an unusual cutaneous tumor.
    Korkolis DP; Liapakis IE; Vassilopoulos PP
    Anticancer Res; 2007; 27(3B):1631-4. PubMed ID: 17595787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.
    Panse G; Reisenbichler E; Snuderl M; Wang WL; Laskin W; Jour G
    J Cutan Pathol; 2021 Feb; 48(2):290-294. PubMed ID: 32519338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dermatofibrosarcoma protuberans: pathology, genetics, and potential therapeutic strategies.
    Thway K; Noujaim J; Jones RL; Fisher C
    Ann Diagn Pathol; 2016 Dec; 25():64-71. PubMed ID: 27806849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays.
    Patel KU; Szabo SS; Hernandez VS; Prieto VG; Abruzzo LV; Lazar AJ; López-Terrada D
    Hum Pathol; 2008 Feb; 39(2):184-93. PubMed ID: 17950782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An unusual clinical presentation of myxoid dermatofibrosarcoma protuberans with a prominent vasculature: A potential pitfall in the diagnosis of myxoid soft tissue tumors.
    Tran P; Henderson GP; McLemore M
    J Cutan Pathol; 2018 Jun; 45(6):419-422. PubMed ID: 29468850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atrophic dermatofibrosarcoma protuberans.
    Sinovich V; Hollowood K; Burge S
    Australas J Dermatol; 2005 May; 46(2):114-7. PubMed ID: 15842408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans--an update.
    Breuninger H; Sebastian G; Garbe C
    J Dtsch Dermatol Ges; 2004 Aug; 2(8):661-7. PubMed ID: 16279228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dermatofibrosarcoma protuberans of the sole.
    Mizushima J; Nogita T; Ooe M; Kawashima M
    Dermatology; 1996; 192(3):280-2. PubMed ID: 8726650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible contribution of PDGF-BB-induced autophagy in dermatofibrosarcoma protuberans: Autophagy marker Atg5 could be a differential marker between dermatofibrosarcoma protuberans and dermatofibroma.
    Motegi SI; Fujiwara C; Sekiguchi A; Yamazaki S; Yokoyama Y; Yasuda M; Ishikawa O
    J Dermatol Sci; 2019 Feb; 93(2):139-141. PubMed ID: 30704939
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunohistochemical characterization of dermatofibrosarcoma protuberans with practical applications for diagnosis and treatment.
    Haycox CL; Odland PB; Olbricht SM; Piepkorn M
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):438-44. PubMed ID: 9308560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.